In patients with T2D who had been hospitalized for poorly controlled blood glucose, SGLT2 inhibitors nearly doubled the risk ...

This discovery shows that a thoughtful combination of medicines can make a big difference in treating complex cases of Type 2 ...

SGLT2 inhibitors and GLP-1 agonists are class 1 medications, but many Medicaid patients have challenges with access.

A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...

Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a ...

This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...

Diabetes, especially type 2 diabetes, is often referred to as a “silent epidemic” because it can develop slowly without ...

While sprinkling cinnamon on food is likely safe, concentrated supplements might pose risks, especially for people taking ...

A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that ...

Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...

"Polydipsia" means "excessive thirst." It can be a symptom of medical conditions such as diabetes, a psychological symptom, ...